Podcasts about sbd

Send us a textLosing weight after 40 can backfire if it's done the wrong way—and in this episode of the Strong By Design Podcast, we uncover why that matters more than ever. Coach Chris Wilson sits down with Dr. Ron Eccles to explore the growing role of peptides and GLP-based therapies in sustainable weight and fat loss. Dr. Eccles breaks down peptides in simple terms, explaining how gut hormones like GLP-1, GLP-2, and GIP influence hunger, metabolism, and body composition. Together, they discuss why weight loss alone doesn't equal better health—and how preserving muscle, protecting joints, and improving metabolic health must be part of the equation.The conversation also tackles America's declining health outcomes, the concept of the “bliss point” in eating behavior, and what truly happens after you reach your target weight. Dr. Eccles shares insights on emerging peptide technologies, common myths around GLPs, and why lifestyle factors like sleep, movement, and nutrition determine long-term success. You'll also hear real-world lessons from clinical practice, including differences between men and women and the key health metrics that actually matter. This episode is a must-listen for anyone curious about modern weight-loss solutions and how to approach them safely, intelligently, and with long-term health in mind. Time Stamps00:00 – Lose weight the wrong way: Hidden dangers for anyone over 4000:56 — Welcome to the Strong by Design podcast!02:20 – Join Coach Chris and special guest Dr. Ron Eccles03:11 – Dr. Ron's 4 pillars of life balance—and why health is a top priority05:06 – Peptides explained: What they are and how they work06:56 – Discover the peptide that started it all10:38 – GLP-1, GLP-2, and GIP: the gut peptides that silence hunger12:53 – Why losing weight isn't the same as building a better body14:48 - Discussion of the abysmal health outcomes in America16:59 – The concept of the “Bliss Point” explained19:06 – What comes next? 3 options after hitting your target21:02 – Next-level peptides: control appetite, burn fat, and save muscle26:50 – The future of peptides: No injections required29:12 – Debunking myths about GLPs33:30 – How chronic joint pain affected Dr. Eccles's wife36:33 – Weight loss differences between men and women37:56 – The 5 key metrics Dr. Eccles tracks with his clients39:18 – The science behind Alpha Shred revealed43:35 – Lifestyle factors that make peptides work47:02 – Why sleep is essential for brain health53:31 – Key advice before your peptide journey55:39 – Why some “unconventional” doctors get it right1:00:26 - Stay connected beyond the episode with Ron Eccles1:03:23 - Fun fact about the Strong by Design Podcast name1:05:23 - Please share and leave ratings & reviews for the SBD podcast! Resources:15-minute Consultation at 941-799-6583Connect with Dr Ron: InstagramStart the New Year with more Focus, Clarity & Mental Energy!Grab some Neuro-Thrive at a Discount - Use Code: SBD2026

N488 - EASD 2025 - Obesidade e Gestação: Atenção redobrada antes, durante e após a gravidez - Dhiãnah Santini e Denise Franco by SBD

N497 - EASD 2025 - Resumo dia 2 by SBD

N496 - EASD 2025 - Tirzepatida, Retatrutida, PG102: Novos caminhos para o tratamento do diabetes e da obesidade - Caio Carneiro, Fernando Valente e Tainã Aci by SBD

N495 - EASD 2025 - Exercício ou Liraglutida: Qual impacto na prevençao da Aterosclerose? - Diandro Mota, Dhiãnah Santini e Cristiano Barcellos by SBD

N494 - EASD 2025 - Transplante de Ilhotas: Novos dados e avanços da vertex - Dhiãnah Santini e Denise Franco by SBD

N493 - EASD 2025 - Tecnologia Digital no Diabetes: Dados do Mysugr e Apple Health na prática - Fernando Valente e Sônia Castilho by SBD

N492 - EASD 2025 - Estudo Da Qing: 34 anos de seguimento mostram impacto na prevenção cardiovascular - Fernando Valente e Bianca Pititto by SBD

N491 - EASD 2025 - Inteligência Artificial no Diabetes: Não é mais o futuro, é o presente - Fernando Valente e Humberto Batista by SBD

N490 - EASD 2025 - Diabetes e Demência: Controle precoce para reduzir o risco - Dhiãnah Santini e Luciana Schreiner by SBD

N489 - EASD 2025 - Resistência Insulínica: Do mecanismo a novas estratégias terapêuticas - Mario Saad e Fernando Valente by SBD

N487 - EASD 2025 - Exercício no Diabetes: Treinar pela manhã ou à tarde faz diferença? - Cristiano Barcellos e Fernando Valente by SBD

N499 - EASD 2025 - SURPASS-CVOT: Tirzepatida versus dulaglutida no controle glicêmico e metabólico! - Fernando Valente e André Vianna by SBD

N486 - EASD 2025 - Diabetes tipo 1 adulto: AABBCC ajuda no diagnóstico correto - Silvana Neiva e Fernando Valente by SBD

N485 - EASD 2025 - Diabetes Tipo 1: Screening populacional e idades-chave para rastreamento - Monica Gabbay e Melanie Rodacki by SBD

N484 - EASD 2025 - Demência: que intervenções têm benefício comprovado? - Marcio Lauria e Fernando Valente by SBD

N483 - EASD 2025 - Registros de Diabetes: Como o Brasil pode avançar com base na experiência Europeia - Solange Travassos e Fernando Valente by SBD

N482 - EASD 2025 - Tratamento na Vida Real: Resultados iguais aos ensaios clínicos? - Fernando Valente e Rodrigo Moreira by SBD

N481 - EASD 2025 - Resistência Insulínica: Estamos tratando da forma certa? - Fernando Valente e João Salles by SBD

N480 - EASD 2025 - Resumo dia 1 by SBD

N479 - EASD 2025 - Hipercortisolismo: O noxious nine de defronzo no diabetes tipo 2 - Virgínia Fernandes e Fernando Valente by SBD

N478 - EASD 2025 - Diabetes Tipo 2: GLP-1 e SGLT2 se destacam após Metformina - André Vianna, Fernando Valente e Melanie Rodacki by SBD

N477 - EASD 2025 - CGM na Cetoacidose Diabética: Acurácia e Segurança na UTI - Fernando Valente e Rosane Kupfer by SBD

N498 - EASD 2025 - SURPASS-CVOT: Tirzepatida mostra segurança cardiovascular e benefício renal em estudo histórico! - Ruy Lyra, Fernando Valente e Luciano Albuquerque by SBD

N500 - EASD 2025 - ATTAIN -1: Orforglipron Oral reduz 11% do peso corporal em obesidade sem diabetes - Dhiãnah Santini by SBD

N525 - EASD 2025 - Resumo dia 4 by SBD

N513 - EASD 2025 - Co-agonistas: Novas combinações com GLP1 mostram resultados promissores em peso, glicemia e fígado! - Dhiãnah Santini e Fernando Valente by SBD

N523 - EASD 2025 - SURPASS-PEDS: Tirzepatida reduz HBA1C e peso em adolescentes com diabetes tipo 2! - Flávia Coimbra, Karen de Marca e Fernando Valente by SBD

N522 - EASD 2025 - Sono, Exercício e Saúde Mental: Como tudo isso impacta o Diabetes? - Solange Travassos e Luciana Schreiner by SBD

N521 - EASD 2025 - Estigma, Culpa e Burnout: Os Desafios psicológicos no Diabetes Tipo 1 - Luciana Schreiner e Fernando Valente by SBD

N520 - EASD 2025 - Novas Estratégias para preservar células beta no Diabetes Tipo 1 - Fernando Valente e Melanie Rodacki by SBD

N519 - EASD 2025 - Antipsicóticos e Diabetes: Efeitos negativos antes do ganho de peso - Franco Folli e Fernando Valente by SBD

N518 - EASD 2025 - Inflamação e Diabetes Tipo 1: Novos Insights sobre o pâncreas exócrino - Solange Travassos e Fernando Valente by SBD

N517 - EASD 2025 - Novo Consenso Internacional: Destaca Mudanças no manejo do Diabetes Tipo 1 no Adulto - Melanie Rodacki e Dhiãnah Santini by SBD

N516- EASD 2025 - GLP-1 e Redução do Álcool: Dados promissores com Liraglutida - Fernando Valente e Silvana Neiva by SBD

N515 -EASD 2025 - Diabetes Tipo 1 no Adulto: Diretrizes destacam diagnósticos e manejo no consultório! - Dhiãnah Santini e Melanie Rodacki by SBD

N514 - EASD 2025 - Resumo dia 3 by SBD

N512 - EASD 2025 - 75 Anos da IDF: SBD representa o Brasil e confirma presença do presidente no congresso 2025 - Ruy Lyra e Bianca Pititto by SBD

N501 - EASD 2025 - Semaglutida + Bimagrumab: Redução de gordura com preservação de massa magra - Dhiãnah Santini e Clayton Macedo by SBD

N511 - EASD 2025 - Diabetes Distress: Novo consenso Europeu reconhece o impacto emocional do diabetes! - Sônia Castilho e Fernando Valente by SBD

N510 - EASD 2025 - Resmetirom: Primeiro tratamento aprovado para MASH - Dhiãnah Santini e Fernando Valente by SBD

N509 - EASD 2025 - GLP-1 e Neuropatia Óptica (NAION): Estudos mostram ausência de risco aumentado - Fernando Valente e Rosane Kupfer by SBD

N508 - EASD 2025 - Cronobiologia no Diabetes: Impacto dos ritmos biológicos no controle glicêmico - Dhiãnah Santini e Fernando Valente by SBD

N507 - EASD 2025 - Validação do Score Escocês-Sueco no Diabetes Tipo 1: Uma nova opção para avaliar o risco cardiovascular - Priscila Aroucha e Fernando Valente by SBD

N506 - EASD 2025 - Semaglutida 7,2 mg: Perda de gordura corporal e redução do Food Noise - Dhiãnah Santini e Virgínia Fernandes by SBD

N505 - EASD 2025 - GLP-1 Oral Semanal: Ecnoglutide mostra eficácia e segurança em estudo inicial - Dhiãnah Santini by SBD

N504 - EASD 2025 - Obesidade: Insights da Camillo Golgi Lecure com Mikael Rydén - Luciano Giacaglia e Fernando Valente by SBD

N503 - EASD 2025 - Glucagon: Ganha novo papel nas terapias para diabetes e obesidade - Fernando Valente e Luciano Giacaglia by SBD

N502 - EASD 2025 - Semaglutida: Reduz amputações em pacientes com doença vascular periférica - Fernando Valente e Luis Canani by SBD

Send us a textIn this special Thanksgiving episode, Coach Chris Wilson dives into the timeless ideas from Adam Grant's bestselling book Give and Take — exploring how gratitude, generosity, and giving back can transform not just your relationships, but your success and happiness as well.As the world slows down for the holiday, this is the perfect time to reflect on who's helped you get where you are, and how you can pour back into others. Chris breaks down the three types of people — Givers, Takers, and Matchers — and shares how adopting a giver's mindset can multiply your impact without burning out.You'll hear insights on:How gratitude fuels generosity — and how giving deepens gratitude.The difference between selfless and “otherish” giving (and why one sustains you while the other drains you).Why leading with generosity creates stronger relationships, richer opportunities, and lasting fulfillment.How to make Thanksgiving more than a holiday — but a habit of the heart.Chris also shares practical ways to live these ideas daily — from small acts of kindness to building a gratitude and giving practice that rewires how you lead, live, and love.This is a heartfelt reminder that success isn't just about what you get — it's about what you give. Because when you give first, everyone wins.Share it with a friend, family member, or teammate who's made a difference in your life. Let them know how much they matter — that's the real spirit of Thanksgiving.Time Stamps00:55 – Welcome to the 'Strong by Design' podcast01:19 – Join Chris Wilson for a special solo episode04:00 – What this episode is all about07:14 – A book that changed Chris's perspective09:28 – Discover the three types of people in life13:45 – Unlocking the concept of 'Otherish Giving'18:31 – How generosity drives long-term impact21:35 – Connecting it all to Thanksgiving24:29 – The power of being in a state of gratitude28:00 – Simple ways to show thankfulness every day31:09 – The ripple effect: small actions, big impact33:35 – A powerful, heartfelt reflection from Chris1:09:42 – Please share and leave ratings & reviews for the SBD podcast!Resources:Give and Take – The BookConnect with Chris:InstagramSupport the showConnect w/ CriticalBench: Youtube Facebook Instagram CriticalBench.com StrongByDesignPodcast.com